| TOX is a critical regulator of tumour-specific T cell differentiation AC Scott, F Dündar, P Zumbo, SS Chandran, CA Klebanoff, M Shakiba, ... Nature 571 (7764), 270-274, 2019 | 803 | 2019 |
| Chromatin states define tumour-specific T cell dysfunction and reprogramming M Philip, L Fairchild, L Sun, EL Horste, S Camara, M Shakiba, AC Scott, ... Nature 545 (7655), 452-456, 2017 | 788 | 2017 |
| Targeting the intracellular WT1 oncogene product with a therapeutic human antibody T Dao, S Yan, N Veomett, D Pankov, L Zhou, T Korontsvit, A Scott, ... Science translational medicine 5 (176), 176ra33-176ra33, 2013 | 220 | 2013 |
| Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1 T Dao, D Pankov, A Scott, T Korontsvit, V Zakhaleva, Y Xu, J Xiang, S Yan, ... Nature biotechnology 33 (10), 1079-1086, 2015 | 172 | 2015 |
| A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens AY Chang, T Dao, RS Gejman, CA Jarvis, A Scott, L Dubrovsky, ... The Journal of clinical investigation 127 (7), 2705-2718, 2017 | 103 | 2017 |
| A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias L Dubrovsky, D Pankov, EJ Brea, T Dao, A Scott, S Yan, RJ O’Reilly, C Liu, ... Blood 123 (21), 3296-3304, 2014 | 60 | 2014 |
| Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells KJ Haro, AC Scott, DA Scheinberg Blood, The Journal of the American Society of Hematology 120 (10), 2087-2097, 2012 | 34 | 2012 |
| Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody T Dao, SS Mun, AC Scott, CA Jarvis, T Korontsvit, Z Yang, L Liu, MG Klatt, ... Oncoimmunology 8 (7), e1570778, 2019 | 26 | 2019 |
| Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy M Zhang, Z Zhao, Y Pritykin, M Hannum, AC Scott, F Kuo, V Sanghvi, ... Science translational medicine 13 (611), eabg4328, 2021 | 9 | 2021 |
